These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33405323)

  • 1. Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients.
    Shikida Y; Mizobuchi M; Yoshitake O; Kato T; Ogata H; Koiwa F; Honda H
    Ther Apher Dial; 2021 Jun; 25(3):331-340. PubMed ID: 33405323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis.
    Thongprayoon C; Neyra JA; Hansrivijit P; Medaura J; Leeaphorn N; Davis PW; Kaewput W; Bathini T; Salim SA; Chewcharat A; Aeddula NR; Vallabhajosyula S; Mao MA; Cheungpasitporn W
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein.
    Akimoto T; Kimura T; Watanabe Y; Ishikawa N; Iwazu Y; Saito O; Muto S; Yagisawa T; Kusano E
    Transplant Proc; 2013; 45(1):134-6. PubMed ID: 23375286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study.
    Drew DA; Katz R; Kritchevsky S; Ix J; Shlipak M; Gutiérrez OM; Newman A; Hoofnagle A; Fried L; Semba RD; Sarnak M
    J Am Soc Nephrol; 2017 Jun; 28(6):1859-1866. PubMed ID: 28104822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of Older Donors' Klotho Level in Predicting Recipients' Short-Term Renal Function.
    Deng G; Yang A; Wu J; Zhou J; Meng S; Zhu C; Wang J; Shen S; Ma J; Liu D
    Med Sci Monit; 2018 Nov; 24():7936-7943. PubMed ID: 30396199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin.
    Leone F; Lofaro D; Gigliotti P; Perri A; Vizza D; Toteda G; Lupinacci S; Armentano F; Papalia T; Bonofiglio R
    J Nephrol; 2014 Oct; 27(5):577-85. PubMed ID: 24760622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ; Kang E; Oh YK; Kim YH; Han SH; Yoo TH; Chae DW; Lee J; Ahn C; Oh KH
    BMC Nephrol; 2018 Mar; 19(1):51. PubMed ID: 29506503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
    Akimoto T; Yoshizawa H; Watanabe Y; Numata A; Yamazaki T; Takeshima E; Iwazu K; Komada T; Otani N; Morishita Y; Ito C; Shiizaki K; Ando Y; Muto S; Kuro-o M; Kusano E
    BMC Nephrol; 2012 Nov; 13():155. PubMed ID: 23176706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
    Tomita Y; Iwadoh K; Ogawa Y; Miki K; Kato Y; Kai K; Sannomiya A; Koyama I; Kitajima K; Nakajima I; Fuchinoue S
    PLoS One; 2019; 14(10):e0224203. PubMed ID: 31644555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower circulating soluble Klotho level is associated with increased risk of all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis.
    Charoenngam N; Ponvilawan B; Ungprasert P
    Int Urol Nephrol; 2020 Aug; 52(8):1543-1550. PubMed ID: 32462356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum klotho levels in acute kidney injury
.
    Seibert E; Radler D; Ulrich C; Hanika S; Fiedler R; Girndt M
    Clin Nephrol; 2017 Apr; 87 (2017)(4):173-179. PubMed ID: 28157067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the Mammalian Target of Rapamycin May Augment the Increase in Soluble Klotho Levels in Renal Transplantation Recipients.
    Mizusaki K; Hasuike Y; Kimura T; Nagasawa Y; Kuragano T; Yamada Y; Nojima M; Yamamoto S; Nakanishi T; Ishihara M
    Blood Purif; 2019; 47 Suppl 2():12-18. PubMed ID: 30943481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
    Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.